Role of gefitinib (G) in heavily pretreated non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Tamburini, E.
Tassinari, D.
Pasquini, E.
Papi, M.
Possenti, C.
Drudi, F.
Castellani, C.
Santelmo, C.
Carloni, F.
Ravaioli, A.
机构：
[1] Dept Oncol, Rimini, Italy
[2] Dept Oncol, Cattolica, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19102
引用
收藏
页数：2
相关论文
共 50 条
  • [31] SYNERGISTIC INTERACTIONS OF GEFITINIB, AFATINIB, CETUXIMAB AND DASATINIB AGAINST GEFITINIB RESISTANT NON-SMALL CELL LUNG CANCER (NSCLC)
    Chang, Alex Y.
    Wang, Miao
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S453 - S453
  • [32] Gefitinib (G) treatment outcome after progression on erlotinib (E) in patients with advanced non-small cell lung cancer (NSCLC)
    Grossi, F.
    Brianti, A.
    Defferrari, C.
    Loprevite, M.
    Catania, G.
    Pronzato, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Difference between skin toxicities in erlotinib (E) and gefitinib (G) in the treatment of advanced non-small cell lung cancer (NSCLC)
    Defferrari, C.
    Loprevite, M.
    Brianti, A.
    Catania, G.
    Grossi, F.
    Pronzato, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
    Araki, Takuya
    Yashima, Hideaki
    Shimizu, Kimihiro
    Aomori, Tohru
    Hashita, Tadahiro
    Kaira, Kyoichi
    Nakamura, Tomonori
    Yamamoto, Koujirou
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [35] Gefitinib (Iressa) trials in non-small cell lung cancer
    Johnson, DH
    LUNG CANCER, 2003, 41 : S23 - S28
  • [36] Gefitinib: an "orphan" drug for non-small cell lung cancer
    Ziogas, Dimitrios C.
    Liontos, Michalis
    Kyriazoglou, Anastasios
    Tsironis, Georgios
    Bamias, Aristotelis
    Dimopoulos, Meletios-Athanasios
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (11): : 899 - 906
  • [37] Gefitinib (Iressa) for advanced non-small cell lung cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2002, 44 (1138): : 77 - 78
  • [38] β-catenin in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Lolljee, J
    Edwards, JG
    Jones, JL
    Cox, G
    Richardson, D
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
  • [39] Micrometastases in non-small cell lung cancer (NSCLC)
    Passlick, B
    LUNG CANCER, 2001, 34 : S25 - S29
  • [40] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
12345